Video
Why My System Loves This Insurance Powerhouse
With near-zero volatility and strong CROCI of 11.7x, Marsh McLennan offers exceptional stability plus AI innovation even during market turbulence.
Buy This, Not That: The Truth About This 7.34% Dividend
This 7.34% dividend looks attractive but isn’t sustainable. There’s a better option for financial stability and semiconductor exposure without tariff concerns.
Monday Takeaways: Why You Should Embrace This Market Pullback
Trading through tough times with an analytical approach
Dealmaker’s Diary: Timing Matters for This Unusual Energy Play
This stock isn’t your typical energy play. Alpesh’s unusual timing strategy for this $3B natural gas provider helps dodge volatility while capturing upside.
Buy This, Not That: Three Reader Stocks… Only One Winner
One stock is in a perfect buy zone… while another’s speculation runs too hot… and the third can’t turn gold into profits.
Friday’s Rally Put Markets at Critical Juncture
Markets are on the cusp of a breakout after Friday’s rally. Will the momentum hold, or is turbulence ahead?
Dealmaker’s Diary: A Massive AI Stock Opportunity
AMD has dropped 50%, but history suggests a major rebound. Here’s why this AI stock could double in the next 1-2 years.
Buy This, Not That: Which Stock Wins The Home Improvement Showdown
Home Depot and Lowe’s both popped on earnings, but one chart reveals why only one deserves your investment dollars right now.
Monday Takeaways: It’s All About Nvidia
NVIDIA’s earnings could move markets big this week. Stay cautious, watch volatility, and be smart with your trades. Key takeaways inside!
This Biotech Has a Tech Company’s DNA
Most biotechs burn cash, but this one’s turning heads with its 34.8x return on invested capital and PE ratio of 18.6x – well below industry average.